Lineage Cell Therapeutics (United States)
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Lineage Cell Therapeutics (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
61%
Total
Publications
285
Total Open
Publications
174
Total
Citations
18K
Open Access
Percentage
61%
Total
Publications
285
Total Open
Publications
174
Total
Citations
18K
Breakdown
Publisher Open
16%
Both
31%
Other Platform Open
14%
Closed
39%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
49
Hybrid 37%
50
No Guarantees 26%
35
Other Platform Open
Domain 75%
98
Institution 45%
59
Preprint 12%
15
Other Internet 12%
15
Public 2%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 99 |
doaj.org OAI-PMH Repository | Institution | 25 |
DOI | Other Internet | 11 |
California Digital Library | Institution | 10 |
bioRxiv | Preprint | 9 |
University of Cambridge | Institution | 8 |
Europe PMC | Domain | 8 |
Unknown Repository | Other Internet | 6 |
Office of Scientific and Technical Information | Institution | 5 |
Washington University in St. Louis | Institution | 3 |